236 related articles for article (PubMed ID: 23706759)
21. Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.
Scherbaum WA; Schweizer A; Mari A; Nilsson PM; Lalanne G; Jauffret S; Foley JE
Diabetes Obes Metab; 2008 Aug; 10(8):675-82. PubMed ID: 18248490
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of vildagliptin as a second-line therapy vs other oral antidiabetic agents in patients with type 2 diabetes: Czech results within the worldwide prospective cohort EDGE study].
Haluzík M; Veselá V; Gerle J; Brada M; Dohnalová L; Edelsberger T; Houdová J
Vnitr Lek; 2013 Dec; 59(12):1049-56. PubMed ID: 24350936
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study.
Iwamoto Y; Kashiwagi A; Yamada N; Terao S; Mimori N; Suzuki M; Tachibana H
Diabetes Obes Metab; 2010 Aug; 12(8):700-8. PubMed ID: 20590747
[TBL] [Abstract][Full Text] [Related]
24. Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.
Garber AJ; Foley JE; Banerji MA; Ebeling P; Gudbjörnsdottir S; Camisasca RP; Couturier A; Baron MA
Diabetes Obes Metab; 2008 Nov; 10(11):1047-56. PubMed ID: 18284434
[TBL] [Abstract][Full Text] [Related]
25. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
Rosenstock J; Fitchet M
Int J Clin Pract Suppl; 2008 Mar; (159):15-23. PubMed ID: 18269437
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea.
Moses RG; Kalra S; Brook D; Sockler J; Monyak J; Visvanathan J; Montanaro M; Fisher SA
Diabetes Obes Metab; 2014 May; 16(5):443-50. PubMed ID: 24205943
[TBL] [Abstract][Full Text] [Related]
27. Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
Kothny W; Lukashevich V; Foley JE; Rendell MS; Schweizer A
Diabetologia; 2015 Sep; 58(9):2020-6. PubMed ID: 26067186
[TBL] [Abstract][Full Text] [Related]
28. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
Bosi E; Dotta F; Jia Y; Goodman M
Diabetes Obes Metab; 2009 May; 11(5):506-15. PubMed ID: 19320662
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Hassanein M; Hanif W; Malik W; Kamal A; Geransar P; Lister N; Andrews C; Barnett A
Curr Med Res Opin; 2011 Jul; 27(7):1367-74. PubMed ID: 21568833
[TBL] [Abstract][Full Text] [Related]
30. Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetes.
Schweizer A; Couturier A; Foley JE; Dejager S
Diabet Med; 2007 Sep; 24(9):955-61. PubMed ID: 17509069
[TBL] [Abstract][Full Text] [Related]
31. Vildagliptin: a review of its use in type 2 diabetes mellitus.
Keating GM
Drugs; 2010 Nov; 70(16):2089-112. PubMed ID: 20964454
[TBL] [Abstract][Full Text] [Related]
32. Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.
Fonseca V; Schweizer A; Albrecht D; Baron MA; Chang I; Dejager S
Diabetologia; 2007 Jun; 50(6):1148-55. PubMed ID: 17387446
[TBL] [Abstract][Full Text] [Related]
33. Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus.
Kikuchi M; Abe N; Kato M; Terao S; Mimori N; Tachibana H
Diabetes Res Clin Pract; 2009 Feb; 83(2):233-40. PubMed ID: 19118913
[TBL] [Abstract][Full Text] [Related]
34. Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus.
Yang W; Xing X; Lv X; Li Y; Ma J; Yuan G; Sun F; Wang W; Woloschak M; Lukashevich V; Kozlovski P; Kothny W;
J Diabetes; 2015 Mar; 7(2):174-81. PubMed ID: 24823599
[TBL] [Abstract][Full Text] [Related]
35. Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.
Garber AJ; Schweizer A; Baron MA; Rochotte E; Dejager S
Diabetes Obes Metab; 2007 Mar; 9(2):166-74. PubMed ID: 17300592
[TBL] [Abstract][Full Text] [Related]
36. Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.
Bolli G; Dotta F; Colin L; Minic B; Goodman M
Diabetes Obes Metab; 2009 Jun; 11(6):589-95. PubMed ID: 19515179
[TBL] [Abstract][Full Text] [Related]
37. Vildagliptin: a new oral treatment for type 2 diabetes mellitus.
Mathieu C; Degrande E
Vasc Health Risk Manag; 2008; 4(6):1349-60. PubMed ID: 19337548
[TBL] [Abstract][Full Text] [Related]
38. Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).
Hermans M; Van Gaal L; Rézette I; Daci E; MacDonald K; Denhaerynck K; Vancayzeele S; De Meester L; Clemens A; Yee B; Abraham I
Prim Care Diabetes; 2016 Dec; 10(6):425-433. PubMed ID: 27388795
[TBL] [Abstract][Full Text] [Related]
39. Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.
Pan C; Yang W; Barona JP; Wang Y; Niggli M; Mohideen P; Wang Y; Foley JE
Diabet Med; 2008 Apr; 25(4):435-41. PubMed ID: 18341596
[TBL] [Abstract][Full Text] [Related]
40. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R; Gruenberger JB; Bader G; Dworak M
Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
